{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:23:00Z","timestamp":1790770980583,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ahj.2026.107361","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:25:08Z","timestamp":1770222308000},"page":"107361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Antiplatelet treatment after drug-coated balloon treatment: Review of the current evidence and future perspectives"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5808-7810","authenticated-orcid":false,"given":"Bernardo","family":"Cortese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Abdelkader","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Malakouti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jegan","family":"Sivalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Chaddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"El-Mokdad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Luca","family":"Gurgoglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107361_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM197907123010201","article-title":"Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty","volume":"301","author":"Gr\u00fcntzig","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107361_bib0002","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent restenosis Study investigators","volume":"331","author":"Fischman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107361_bib0003","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2017.05.057","article-title":"Should we still have bare-metal stents available in our catheterization laboratory?","volume":"70","author":"Colombo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0004","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIRCULATIONAHA.120.046308","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107361_bib0005","first-page":"465","article-title":"Stent thrombosis after percutaneous coronary intervention: from bare-metal to the last generation of drug-eluting stents","volume":"11","author":"Polimeni","year":"2022","journal-title":"Interv Cardiol Clin"},{"key":"10.1016\/j.ahj.2026.107361_bib0006","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107361_bib0007","first-page":"436","article-title":"Coronary anatomy and comorbidities impact on elective PCI outcomes in left main and multivessel coronary artery disease","volume":"98","author":"Yager","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013242","article-title":"Short-term DAPT and DAPT de-escalation strategies for patients with acute coronary syndromes: a systematic review and network meta-analysis","volume":"16","author":"Kuno","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0009","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCULATIONAHA.118.038065","article-title":"Ten-year clinical outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease","volume":"139","author":"Kufner","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107361_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027055","article-title":"Long-term outcomes and duration of dual antiplatelet therapy after coronary intervention with second-generation drug-eluting stents: the veterans affairs extended DAPT study","volume":"12","author":"Kinlay","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2026.107361_bib0011","first-page":"1069","article-title":"The evolution and revolution of drug coated balloons in coronary angioplasty: an up-to-date review of literature data","volume":"102","author":"Cortese","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0012","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig Lecture ESC 2014","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107361_bib0013","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4244\/EIJ-D-23-00849","article-title":"Predictors of late lumen enlargement after drug-coated balloon angioplasty for de novo coronary lesions","volume":"20","author":"Yamamoto","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2026.107361_bib0014","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ahj.2024.08.003","article-title":"Pathological evaluation of predictors for delayed endothelial coverage after currently available drug-eluting stent implantation in coronary arteries: impact of lesions with acute and chronic coronary syndromes","volume":"277","author":"Aihara","year":"2024","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107361_bib0015","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","article-title":"A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study","volume":"60","author":"Latib","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0016","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial","volume":"392","author":"Jeger","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ahj.2026.107361_bib0017","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","article-title":"Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial","volume":"396","author":"Jeger","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ahj.2026.107361_bib0018","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","article-title":"Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial","volume":"13","author":"Cortese","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0019","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jcin.2023.02.011","article-title":"Long-term outcome of drug-coated balloon vs drug-eluting stent for small coronary vessels: PICCOLETO-II 3-year follow-up","volume":"16","author":"Cortese","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0020","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.jcin.2018.09.009","article-title":"Drug-coated balloon versus drug-eluting stent for small-vessel disease: the RESTORE SVD China randomized trial","volume":"11","author":"Tang","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"Suppl 1","key":"10.1016\/j.ahj.2026.107361_bib0021","first-page":"587","article-title":"Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: the RESTORE Small Vessel Disease China trial","volume":"95","author":"Tian","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0022","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0140-6736(24)01594-0","article-title":"Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial","volume":"404","author":"Gao","year":"2024","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ahj.2026.107361_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082945","article-title":"Stepwise dual antiplatelet therapy de-escalation in patients after drug coated balloon angioplasty (REC-CAGEFREE II): multicentre, randomised, open label, assessor blind, non-inferiority trial","volume":"388","author":"Gao","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2026.107361_bib0024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.carrev.2024.07.021","article-title":"Angiographic and clinical impact of balloon inflation time in percutaneous coronary interventions with sirolimus-coated balloon: a subanalysis of the EASTBOURNE study","volume":"73","author":"Gurgoglione","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ahj.2026.107361_bib0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamacardio.2024.4244","article-title":"Drug-coated balloons for the treatment of coronary artery disease: a review","volume":"10","author":"Camaj","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0026","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/futurepharmacol4040041","article-title":"Paclitaxel-coated versus sirolimus-coated eluting balloons for percutaneous coronary interventions: pharmacodynamic properties, clinical evidence, and future perspectives","volume":"4","author":"Gurgoglione","year":"2024","journal-title":"Future Pharmacol"},{"key":"10.1016\/j.ahj.2026.107361_bib0027","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jcin.2022.01.012","article-title":"Treatment of coronary de Novo lesions by a sirolimus- or paclitaxel-coated balloon","volume":"15","author":"Ahmad","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0028","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.jcin.2023.09.026","article-title":"A prospective randomized trial comparing sirolimus-coated balloon with paclitaxel-coated balloon in De Novo small vessels","volume":"16","author":"Ninomiya","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0029","doi-asserted-by":"crossref","first-page":"e1322","DOI":"10.4244\/EIJ-D-23-00868","article-title":"A randomised trial of sirolimus- versus paclitaxel-coated balloons for de novo coronary lesions","volume":"20","author":"Scheller","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2026.107361_bib0030","first-page":"625","article-title":"Comparison of sirolimus-versus paclitaxel-coated balloons in coronary artery disease: one-year results of two real-world prospective registries","volume":"106","author":"Vlieger","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carrev.2021.04.013","article-title":"Comparison between sirolimus- and paclitaxel-coated balloon for revascularization of coronary arteries: the SIRPAC (SIRolimus-PAClitaxel) study","volume":"28","author":"Cortese","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ahj.2026.107361_bib0032","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","article-title":"Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis","volume":"75","author":"Giacoppo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0033","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/eurheartj\/ehaf002","article-title":"Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study","volume":"46","author":"Fezzi","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107361_bib0034","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/s12872-023-03633-w","article-title":"Drug-coated balloons versus drug-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention: an updated meta-analysis with trial sequential analysis","volume":"23","author":"Abdelaziz","year":"2023","journal-title":"BMC Cardiovasc Dis"},{"key":"10.1016\/j.ahj.2026.107361_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132436","article-title":"Sirolimus-coated balloon versus drug-eluting stent for complex coronary lesions. A propensity matched comparison","volume":"415","author":"Iwa\u0144czyk","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0036","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.carrev.2025.04.002","article-title":"Efficacy of drug-coated balloon angioplasty for coronary chronic total occlusion: a systematic review and meta-analysis","volume":"75","author":"Gurgoglione","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ahj.2026.107361_bib0037","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.amjcard.2025.08.012","article-title":"Sirolimus-coated balloon versus drug-eluting stent in elderly patients with coronary artery disease: a matched-based comparison","volume":"255","author":"Gurgoglione","year":"2025","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0038","first-page":"569","article-title":"Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk: single center experience of a novel concept","volume":"101","author":"R\u00e4s\u00e4nen","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0039","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028413","article-title":"Single-antiplatelet treatment after coronary angioplasty with drug-coated balloon","volume":"12","author":"Cortese","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2026.107361_bib0040","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1080\/17512433.2022.2121702","article-title":"Clinical pharmacology of antiplatelet drugs","volume":"15","author":"Gelbenegger","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.ahj.2026.107361_bib0041","series-title":"StatPearls","article-title":"Salicylic acid (Aspirin)","author":"Arif","year":"2025"},{"key":"10.1016\/j.ahj.2026.107361_bib0042","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/14656566.2011.550573","article-title":"Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor","volume":"12","author":"Giorgi","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ahj.2026.107361_bib0043","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107361_bib0044","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107361_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4244\/AIJ-D-23-00010","article-title":"A 2024 scientific update on the clinical performance of drug-coated balloons","volume":"10","author":"Lazar","year":"2024","journal-title":"AsiaIntervention"},{"key":"10.1016\/j.ahj.2026.107361_bib0046","article-title":"Long-term benefits of drug-coated balloons for coronary artery revascularization","author":"Cortese","year":"2023","journal-title":"Minerva Cardiol Angiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0047","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6548696","article-title":"Drug coated balloon-only strategy in De Novo lesions of large coronary vessels","volume":"2019","author":"Rosenberg","year":"2019","journal-title":"J Intervent Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0048","first-page":"181","article-title":"Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: the DCB-only all-comers registry","volume":"93","author":"Rosenberg","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0049","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028413","article-title":"Single-antiplatelet treatment after coronary angioplasty with drug-coated balloon","volume":"12","author":"Cortese","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2026.107361_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial","volume":"66","author":"Alfonso","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0051","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcin.2017.10.024","article-title":"A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis: the DARE trial","volume":"11","author":"Baan","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0052","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2024.1361","article-title":"Paclitaxel-coated balloon vs uncoated balloon for coronary in-stent restenosis: the AGENT IDE randomized clinical trial","volume":"331","author":"Yeh","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2026.107361_bib0053","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00392-018-1346-8","article-title":"Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute","volume":"108","author":"Yu","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0054","first-page":"1016","article-title":"Duration of dual antiplatelet therapy in elective drug-coated balloon angioplasty","volume":"96","author":"Corballis","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","article-title":"Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial","volume":"394","author":"Rissanen","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ahj.2026.107361_bib0056","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jcin.2016.06.056","article-title":"Contemporary approach to coronary bifurcation lesion treatment","volume":"9","author":"Sawaya","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0057","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4244\/EIJ-D-20-00169","article-title":"Percutaneous coronary intervention for bifurcation coronary lesions: the 15th consensus document from the European Bifurcation Club","volume":"16","author":"Burzotta","year":"2021","journal-title":"Eurointervention"},{"key":"10.1016\/j.ahj.2026.107361_bib0058","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00392-014-0671-9","article-title":"Treatment of coronary de novo bifurcation lesions with DCB only strategy","volume":"103","author":"Schulz","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2024.08.067","article-title":"Drug-coated balloon angioplasty of the side branch during provisional stenting: the multicenter randomized DCB-BIF trial","volume":"85","author":"Gao","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ahj.2013.10.011","article-title":"Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque: a 3-vessel optical coherence tomography study","volume":"167","author":"Vergallo","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107361_bib0061","doi-asserted-by":"crossref","first-page":"e898","DOI":"10.4244\/EIJ-D-21-00181","article-title":"Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition","volume":"17","author":"Gragnano","year":"2021","journal-title":"Eurointervention"},{"key":"10.1016\/j.ahj.2026.107361_bib0062","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ahj.2019.10.001","article-title":"Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: insights from the BleeMACS and RENAMI registries","volume":"220","author":"D\u2019Ascenzo","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107361_bib0063","first-page":"893","article-title":"Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: an all-comers registry study","volume":"93","author":"Uskela","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0064","first-page":"843","article-title":"Safety and efficacy of drug-eluting stents for patients at high risk of bleedings: a network meta-analysis","volume":"103","author":"Giacobbe","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0065","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamacardio.2021.5244","article-title":"Comparison of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary syndrome: the STOPDAPT-2 ACS randomized clinical trial","volume":"7","author":"Watanabe","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0066","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.jcin.2023.08.014","article-title":"1- or 3-month DAPT in patients with HBR with or without oral anticoagulant therapy after PCI","volume":"16","author":"Valgimigli","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0067","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.jcin.2023.05.005","article-title":"Sirolimus-coated balloon in an all-comer population of coronary artery disease patients: the EASTBOURNE prospective registry","volume":"16","author":"Cortese","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0068","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.carrev.2024.07.024","article-title":"Safety and efficacy of single antiplatelet therapy in a large cohort of patients treated with sirolimus-coated balloon: post hoc analysis from the prospective EASTBOURNE registry","volume":"74","author":"Mangier","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ahj.2026.107361_bib0069","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4244\/EIJ-D-22-00886","article-title":"Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study","volume":"19","author":"van der Sangen","year":"2023","journal-title":"Eurointervention"},{"key":"10.1016\/j.ahj.2026.107361_bib0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082561","article-title":"P2Y12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials","volume":"389","author":"Giacoppo","year":"2025","journal-title":"BMJ"},{"issue":"Suppl K","key":"10.1016\/j.ahj.2026.107361_bib0071","doi-asserted-by":"crossref","first-page":"K106","DOI":"10.4244\/EIJV7SKA18","article-title":"Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons","volume":"7","author":"Bonaventura","year":"2011","journal-title":"Eurointervention"},{"key":"10.1016\/j.ahj.2026.107361_bib0072","first-page":"427","article-title":"Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology","volume":"83","author":"Cortese","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0073","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107361_bib0074","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5603\/CJ.a2019.0093","article-title":"Drug-coated balloon treatment in coronary artery disease: recommendations from an Asia-Pacific Consensus Group","volume":"28","author":"Her","year":"2021","journal-title":"Cardiol J"},{"key":"10.1016\/j.ahj.2026.107361_bib0075","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(15)00057-4","article-title":"Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial","volume":"386","author":"van Nunen","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2026.107361_bib0076","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107361_bib0077","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4244\/EIJ-D-20-00052","article-title":"Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores","volume":"16","author":"Ueki","year":"2020","journal-title":"Eurointervention"},{"key":"10.1016\/j.ahj.2026.107361_bib0078","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ehjcvp\/pvaa106","article-title":"PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY","volume":"8","author":"Gragnano","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.ahj.2026.107361_bib0079","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjcard.2024.12.015","article-title":"Predictors and long-term prognostic significance of bailout stenting during percutaneous coronary interventions with Sirolimus-Coated balloon: a subanalysis of the Eastbourne study","volume":"239","author":"Gurgoglione","year":"2025","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107361_bib0080","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(23)02454-6","article-title":"Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis","volume":"403","author":"Stone","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2026.107361_bib0081","first-page":"1951","article-title":"The predictive value of quantitative flow ratio and its derived angiographic microvascular resistance for restenosis following drug-coated balloon angioplasty","volume":"106","author":"Wang","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107361_bib0082","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jcin.2024.04.014","article-title":"Intravascular ultrasound vs angiography-guided drug-coated balloon angioplasty: the ULTIMATE \u2162 trial","volume":"17","author":"Gao","year":"2024","journal-title":"JACC Cardiovasc Interv"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:09:58Z","timestamp":1779091798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870326000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":82,"alternative-id":["S0002870326000232"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107361","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiplatelet treatment after drug-coated balloon treatment: Review of the current evidence and future perspectives","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107361"}}